Fatima Aharchi

Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients

H. W. Reesink, Gregory Fanning, Khalid Abou Farha et al. · Gastroenterology · 2009 · 155 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone

Monika Schöller‐Gyüre, Thomas N. Kakuda, Brian Woodfall et al. · Contraception · 2009 · 35 citations

Medicine, Pharmacokinetics, Pharmacology +3

Assessment of the steady‐state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers

Monika Schöller‐Gyüre, Goedele De Smedt, Geerard L. Beets et al. · HIV Medicine · 2009 · 31 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects

Thomas N. Kakuda, Rodica M. Van Solingen-Ristea, Joelle Onkelinx et al. · The Journal of Clinical Pharmacology · 2013 · 18 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY

Hendrik W. Reesink, René Verloes, Khalid Abou Farha et al. · Journal of Hepatology · 2008 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7